Dr. Hirsch is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
5841 S Maryland Ave
Mc 4076, Amb M410
Chicago, IL 60637Phone+1 773-702-4755Fax+1 773-702-2182- Is this information wrong?
Education & Training
- Technion-Israel Inst of Technology Faculty of MedicineClass of 2007
Certifications & Licensure
- IL State Medical License 2014 - 2016
Publications & Presentations
PubMed
- 5 citationsHigher Maintenance Adalimumab Trough Levels are Associated With Achievement of Advanced Remission Targets in Patients With Inflammatory Bowel Disease.Einat Ritter, Ayal Hirsch, Naomi Fliss Isakov, Yulia Ron, Nathaniel A. Cohen, Nitsan Maharshak> ;Journal of Clinical Gastroenterology. 2020 Oct 14
- 28 citationsVedolizumab is effective and safe in elderly inflammatory bowel disease patients: a binational, multicenter, retrospective cohort study:Nathaniel A. Cohen, Nikolas Plevris, Uri Kopylov, Anna Grinman, Bella Ungar, Henit Yanai, Haim Leibovitzh, Naomi Fliss Isakov, Ayal Hirsch, Einat Ritter, Yulia Ron, Ar...> ;United European Gastroenterology Journal. 2020 Aug 17
- 5 citationsDevelopment and validation of processed foods questionnaire (PFQ) in adult inflammatory bowel diseases patientsChen Sarbagili-Shabat, Shira Zelber-Sagi, Naomi Fliss Isakov, Yulia Ron, Ayal Hirsch, Nitsan Maharshak> ;European Journal of Clinical Nutrition. 2020 Apr 22
- Join now to see all
Journal Articles
- Correction to: Risk Factors for Clostridium Difficile Isolation in Inflammatory Bowel Disease: A Prospective StudySushila Dalal, Vijaya L Rao, Laura R Glick, Russell Cohen, Ayal Hirsch, Dejan Micic, Joel Pekow, Atsushi Sakuraba, David T Rubin, Digestive Diseases and Sciences
Other Languages
- Hebrew
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: